Identification of high‐dimensional omics‐derived predictors for tumor growth dynamics using machine learning and pharmacometric modeling
Abstract Pharmacometric modeling can capture tumor growth inhibition (TGI) dynamics and variability. These approaches do not usually consider covariates in high‐dimensional settings, whereas high‐dimensional molecular profiling technologies ("omics") are being increasingly considered for p...
Saved in:
Main Authors: | Laura B. Zwep (Author), Kevin L. W. Duisters (Author), Martijn Jansen (Author), Tingjie Guo (Author), Jacqueline J. Meulman (Author), Parth J. Upadhyay (Author), J. G. Coen vanHasselt (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of machine learning methods for covariate data imputation in pharmacometrics
by: Dominic Stefan Bräm, et al.
Published: (2022) -
Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations
by: Alexander Janssen, et al.
Published: (2022) -
Metaheuristics for pharmacometrics
by: Seongho Kim, et al.
Published: (2021) -
Machine Learning Advanced Dynamic Omics Data Analysis for Precision Medicine
Published: (2020) -
Two new user‐friendly methods to assess pharmacometric parameter identifiability on categorical and continuous scales
by: Martijn vanNoort, et al.
Published: (2024)